During our 100+ years as a full-service, growth investment bank, we‘ve empowered our clients’ success by delivering a depth and breadth of insights across a broad range of sectors and capabilities.
Ahead of the Curve®
Sep 19, 2023
Investors Guide to Immuno-Oncology
Read More >
Podcast
Jul 24, 2023
Biotech And The Inflation Reduction Act: Sussing Out The IRA
Read More >
Ahead of the Curve®
Jun 9, 2023
5th Annual Investor Primer on Antibody Drug Conjugates
Read More >
Podcast
Apr 27, 2023
Owning It In The Biotech C-Suite
Read More >
Ahead of the Curve®
Mar 13, 2023
The Biotech Executive: Bold, Tenacious, And Accountable
Read More >
Video
Mar 8, 2023
Women Leaders in Biopharma
Read More >
Video
Mar 3, 2023
Innovators in Biotech
Read More >
Ahead of the Curve®
Jan 27, 2023
Drug Pricing Survey Again Suggests Positive Outlook
Read More >
Ahead of the Curve®
Jan 27, 2023
The Price Is (Not) Right: Discounts, 340B, Access, And IRA
Read More >
Podcast
Jan 6, 2023
Women Leaders In Biotech VC
Read More >
Ahead of the Curve®
Dec 16, 2022
Speeding Innovation: A Primer on AI in Pharma R&D
Read More >
Ahead of the Curve®
Dec 15, 2022
Obesity Market Poised to Deliver on Outsized Potential
Read More >
In order to optimize our website for you and to be able to continuously improve it, we use cookies. By continuing to use the website, you agree to the use of cookies. Further information on cookies can be found in our Privacy Policy.
